MariaVelezMD

PubMed

• 2 citations
  Consent document translation expense hinders inclusive clinical trial enrolment.
  Maria A Velez, Beth A Glenn, Maria Garcia-Jimenez, Amy L Cummings, Aaron Lisberg, Andrea Nañez, Yazeed Radwan, Jackson P Lind-Lebuffe, Paige M Brodrick, Debory Y Li, M...> ;Nature. 2023 Aug 1
• Is There a Place for Temozolomide plus Nivolumab among Neuroendocrine Neoplasms?
  Maria A Velez, Edward B Garon> ;Clinical Cancer Research. 2023 Feb 16
• What is the current role of immunotherapy in EGFR mutant advanced NSCLC?
  Maria A Velez, Hsin Hsiang Clarence Tsai, David B Shackelford, Edward B Garon, Aaron Lisberg> ;Lung Cancer. 2022 Apr 1
• 62 citations
  Severity of COVID-19 in patients with lung cancer: evidence and challenges.
  Antonio Passaro, Christine M. Bestvina, Maria Velez Velez, Marina Chiara Garassino, Edward B. Garon, Solange Peters> ;Journal for Immunotherapy of Cancer. 2021 Mar 1
• 57 citations
  Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck.
  Dan P. Zandberg, Ashley V. Menk, Maria A. Velez, Daniel P. Normolle, Kristin DePeaux, Angen Liu, Robert L. Ferris, Greg M. Delgoffe> ;Journal for Immunotherapy of Cancer. 2021 May 1
• 3 citations
  Immune-Related Adverse Events (irAEs): Implications for Immune Checkpoint Inhibitor Therapy.
  Nanruoyi Zhou, Maria Velez, Dwight H. Owen, Aaron Lisberg> ;Journal of the National Comprehensive Cancer Network. 2020 Sep 1
• 11 citations
  Is the game over for PD-1 inhibitors in EGFR mutant non-small cell lung cancer?
  Maria A. Velez, Timothy F. Burns> ;Translational Lung Cancer Research. 2019 Apr 29
• 6 citations
  Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC.
  Nanruoyi Zhou, Maria A. Velez, Benjamin Bachrach, Jaklin Gukasyan, Charlene M. Fares, Amy L. Cummings, Jackson P. Lind-Lebuffe, Wisdom O. Akingbemi, Debory Y. Li, Paig...> ;Lung Cancer. 2021 Aug 30
• 7 citations
  The estrogen pathway as a modulator of response to immunotherapy.
  Maria A. Velez, Timothy F. Burns, Laura P. Stabile> ;Immunotherapy. 2019 Jul 30
• 4 citations
  Immunologic mediators of outcome for irradiated oropharyngeal carcinoma based on human papillomavirus status.
  Jessica Meshman, Maria A. Velez, Pin-Chieh Wang, Elliot Abemayor, Maie A. St. John, Deborah Wong, Sunita Bhuta, Allen M. Chen> ;Oral Oncology. 2019 Jan 4
• 2 citations
  FDG-PET metabolic tumor parameters for the reirradiation of recurrent head and neck cancer.
  Maria A. Velez, Darlene Veruttipong, Pin-Chieh Wang, E. Abemayor, Maie A. St. John, M.J. Tennapel, Allen M. Chen> ;The Laryngoscope. 2018 Oct 1
• 6 citations
  Prognostic significance of HPV status in the re-irradiation of recurrent and second primary cancers of the head and neck.
  Maria A. Velez, Pin-Chieh Wang, Sophia Hsu, Robert Chin, Philip Beron, Elliot Abemayor, Maie A. St. John, Allen M. Chen> ;American Journal of Otolaryngology. 2018 May 1
• 4 citations
  Comparison of patient-reported acute urinary and sexual toxicity scores in a 6- versus 2-fraction course of high-dose-rate prostate brachytherapy monotherapy.
  Omar Ragab, Robyn Banerjee, Sang-June Park, Shyamal Patel, Mingle Zhang, Jason Wang, Maria A. Velez, D.J. Demanes, Mitchell Kamrava> ;Journal of Medical Imaging and Radiation Oncology. 2018 Feb 1
• 22 citations
  Tolerance of the Brachial Plexus to High-Dose Reirradiation.
  Allen M. Chen, Taeko Yoshizaki, Maria A. Velez, Argin G. Mikaeilian, Sophia Hsu, Minsong Cao> ;International Journal of Radiation Oncology, Biology, Physics. 2017 May 1
• 15 citations
  Re-irradiation for recurrent and second primary cancers of the head and neck.
  Maria A. Velez, Darlene Veruttipong, Pin-Chieh Wang, Robert Chin, Philip Beron, Elliot Abemayor, Maie A. St. John, Allen M. Chen> ;Oral Oncology. 2017 Apr 1
• 184 citations
  Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non–Small Cell Lung Cancer
  Christina K. Speirs, Todd A. DeWees, Sana Rehman, A. Molotievschi, Maria A. Velez, Daniel Mullen, Sandra Fergus, Marco Trovo, Jeffrey D. Bradley, Cliff G. Robinson> ;Journal of Thoracic Oncology. 2017 Feb 1
• Join now to see all

Lectures

• The HGF-MET signaling pathway is enriched in LUAC brain metastases. 
  2019 ASCO Annual Meeting - 6/1/2019